Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Excellent growth
About
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overpriced on P/E.
Target Price
The average target price of SMTI is 36 and suggests 85% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell